- $60.32m
- $52.30m
- $19.49m
- 79
- 46
- 57
- 65
Annual balance sheet for Health In Tech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 1.49 | 2.42 | 7.85 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 0.977 | 3.92 | 2.15 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 25.4 | 6.86 | 10.8 |
| Net Property, Plant And Equipment | 0.322 | 0.267 | 0.206 |
| Net Intangible Assets | |||
| Long Term Notes Receivable | |||
| Other Long Term Assets | |||
| Total Assets | 28.6 | 11.5 | 15.8 |
| Payable / Accrued | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 24 | 4.78 | 2.13 |
| Total Long Term Debt | |||
| Total Debt | |||
| Deferred Income Tax | |||
| Minority Interest | |||
| Total Other Liabilities | |||
| Total Liabilities | 24.9 | 5.41 | 2.6 |
| Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 3.62 | 6.09 | 13.2 |
| Total Liabilities & Shareholders' Equity | 28.6 | 11.5 | 15.8 |
| Total Common Shares Outstanding |